Trade Desk (NASDAQ:TTD) PT Raised to $112.00 at Citigroup
The Cerbat Gem - 2024-05-11T14:34:41.000Z

Trade Desk (NASDAQ:TTD – Get Free Report) had its price objective lifted by research analysts at Citigroup from $110.00 to $112.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has a “buy” rating on the technology company’s stock. Citigroup’s target price indicates a potential upside of 28.35% from the […]

In related news

Vericel (NASDAQ:VCEL) PT Raised to $55.00 at HC Wainwright
Vericel (NASDAQ:VCEL – Get Free Report) had its price target upped by equities research analysts at HC Wainwright from $53.00 to $55.00 in a research report issued on Thursday, Benzinga reports. The brokerage currently has a “buy” rating on the biotechnology company’s stock. HC Wainwright’s target price indicates a potential upside of 13.05% from the […]
- Related Articles
- In News
- From The Cerbat Gem
- 2024-05-09T18:54:45.000Z
CRISPR Therapeutics (NASDAQ:CRSP) PT Raised to $52.00 at Robert W. Baird
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target increased by stock analysts at Robert W. Baird from $46.00 to $52.00 in a research report issued on Thursday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. Robert W. Baird’s price target suggests a potential upside of 1.62% from the […]
- Related Articles
- In News
- From The Cerbat Gem
- 2024-05-11T14:06:45.000Z
The Trade Desk (NASDAQ:TTD) Exceeds Q1 Expectations, Provides Encouraging Quarterly Guidance
Advertising software maker The Trade Desk (NASDAQ:TTD) reported Q1 CY2024 results beating Wall Street analysts' expectations, with revenue up 28.3% year on year to $491.3 million. Guidance for next quarter's revenue was also better than expected at $575 million at the midpoint, 1.4% above analysts' estimates. It made a non-GAAP profit of $0.26 per share, improving from its profit of $0.02 per share in the same quarter last year.
- Related Articles
- In News
- From Yahoo Finance
- 2024-05-08T20:18:44.000Z

In related news

Vericel (NASDAQ:VCEL) PT Raised to $55.00 at HC Wainwright

CRISPR Therapeutics (NASDAQ:CRSP) PT Raised to $52.00 at Robert W. Baird

The Trade Desk (NASDAQ:TTD) Exceeds Q1 Expectations, Provides Encouraging Quarterly Guidance